rawfin.tv
Viatris Reports Strong Q2 Results, Raises Full-Year Guidance
EarningsstocksAI Generated

Viatris Reports Strong Q2 Results, Raises Full-Year Guidance

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Viatris Inc. announced robust second-quarter 2026 financial results, reporting $3.8 billion in revenues and 3.5% operational growth year-over-year. The pharmaceutical company also raised its full-year guidance, signaling confidence in continued performance.

VTRSPharmaceuticalsEarningsGuidanceHealthcare

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks